Telix and ITM Agree Transformational Radiopharmaceutical Merger
Telix agreed to acquire 100% of Germany-based ITM for US$1.65 billion upfront, with up to US$700 million of contingent consideration. The transaction would combine Telix’s imaging and therapeutic portfolio with ITM’s scaled lutetium-177 supply,…
